FOR IMMEDIATE RELEASE | Wed Jul 19 13:17:00 EDT 2017

‘Nano-in-micro’ stem cell delivery could rescue blood flow after injury

"Nano-In-Micro System for Enhanced Stem Cell Therapy of Ischemic Diseases"
ACS Central Science

When blood flow is reduced or cut to tissues, cells are deprived of oxygen and nutrients, which can lead to cell death if blood flow isn’t efficiently restored. Stem cells are promising treatments, but they do not tend to stay at the site or survive long enough to heal the damage. Today in ACS Central Science, researchers combine micro and nano approaches to improve stem cell therapies and outcomes after ischemia, or inadequate blood supply.

Xiaoming “Shawn” He, Zhenguo Liu and colleagues recognized that in order to improve the viability of stem cell treatments for ischemia, it was crucial to continuously deliver molecules like growth factors to help the stem cells survive and develop into new blood vessels. Nanoparticles are good at this sort of biomolecule delivery, but they tend to drag the cargo inside cells. To treat ischemia, the growth factors need to stay outside the cells. The researchers hypothesized that bigger particles could do the trick.

The researchers encapsulated a growth factor inside nanoparticles first to protect them from degradation, and then placed the nanoparticles inside much larger hydrogel microcapsules that cannot be taken up by cells. This design provided long-term protection and delivery of the growth factor. When the authors tested their system in a mouse model of ischemia, they observed successful differentiation of stem cells, growth of blood vessels and the restoration of blood supply, collectively rescuing muscle tissue and saving the limbs of the mice.

The authors acknowledge funding from the National Institutes of Health, the National Science Foundation and The Ohio State University.

The American Chemical Society, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive press releases from the American Chemical Society, contact newsroom@acs.org.

###

Note: ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies.

Follow us:  

Media Contact

ACS Newsroom
newsroom@acs.org

Katie Cottingham, Ph.D.
301-775-8455
k_cottingham@acs.org